Leadership Overview
LabConnect has 4 executives leading key functions including financial strategy, technology infrastructure, fiscal oversight, and corporate legal governance.
Focused on accelerating global clinical research, LabConnect delivers scalable laboratory solutions to advance therapeutic development and improve health outcomes through specialized testing services.
Focused on accelerating global clinical research, LabConnect delivers scalable laboratory solutions to advance therapeutic development and improve health outcomes through specialized testing services.
Leadership Roles at LabConnect
Mitch Blumenfeld - Chief Financial Officer
Mitch Blumenfeld, the Chief Financial Officer at LabConnect, directs all fiscal operations and long-term capital planning. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust resource allocation for global clinical trial support. This leadership role involves managing complex budgetary requirements across diverse therapeutic areas like oncology and gene therapy. By optimizing financial workflows, Mitch Blumenfeld directly impacts the ability of the company to scale laboratory services for international clients. Blumenfeld maintains rigorous oversight of fiscal reporting standards, ensuring transparency and stability for stakeholders. Through strategic investment in technology-driven laboratory infrastructure, the Chief Financial Officer supports the overarching mission of accelerating medicine development. Ultimately, Blumenfeld secures the necessary financial foundation to sustain high-performance research environments, driving growth across North American and international markets while maintaining strict adherence to corporate financial objectives and long-term sustainability goals.
)
Michael Lalor - Interim Chief Financial Officer & Vice President, Finance
Michael Lalor, the Interim Chief Financial Officer & Vice President, Finance at LabConnect, manages day-to-day financial operations and internal accounting controls. Overseeing the financial reporting processes, the Interim Chief Financial Officer & Vice President, Finance ensures precise tracking of expenditures related to clinical trial support services. This leadership role involves coordinating with department heads to align operational spending with corporate objectives. By refining internal financial procedures, Michael Lalor directly impacts the efficiency of resource utilization across the organization. Lalor monitors cash flow and budgetary performance to support the ongoing expansion of laboratory testing capabilities. Through meticulous analysis of financial data, the Interim Chief Financial Officer & Vice President, Finance provides actionable insights to the executive team for informed decision-making. Ultimately, Lalor maintains fiscal discipline, ensuring that the company possesses the necessary liquidity to meet the demands of global clinical research partners while upholding high standards of financial integrity.
Richard (Rich) LaBarca - Chief Technology Officer
Richard (Rich) LaBarca, the Chief Technology Officer at LabConnect, architects the digital infrastructure powering global clinical trial management. Overseeing the integration of advanced laboratory data systems, the Chief Technology Officer ensures seamless connectivity for specialty and bioanalytical testing services. This leadership role involves driving innovation in software platforms to enhance trial efficiency and data accuracy for pharmaceutical partners. By modernizing technical frameworks, Richard (Rich) LaBarca directly impacts the speed and reliability of clinical research milestones. LaBarca manages cross-functional teams to implement scalable technology solutions that support complex therapeutic programs. Through the deployment of secure, high-capacity data environments, the Chief Technology Officer enables real-time oversight of global testing operations. Ultimately, LaBarca maintains the technological edge required to navigate the evolving landscape of clinical research, ensuring that digital capabilities remain aligned with the mission of improving health outcomes through superior, technology-driven laboratory support services.
Jason Soni - Chief Legal Officer & Corporate Secretary
Jason Soni, the Chief Legal Officer & Corporate Secretary at LabConnect, directs all legal strategy and corporate governance initiatives. Overseeing regulatory compliance across international jurisdictions, the Chief Legal Officer & Corporate Secretary ensures that clinical trial support services meet stringent global standards. This leadership role involves managing complex contractual agreements with pharmaceutical clients and research institutions. By mitigating legal risks, Jason Soni directly impacts the operational security of the company. Soni provides essential guidance on intellectual property protection and corporate policy, ensuring alignment with the mission of accelerating medicine development. Through the management of board relations and corporate records, the Chief Legal Officer & Corporate Secretary maintains high standards of organizational transparency. Ultimately, Soni safeguards the interests of the company, providing the legal framework necessary to navigate the intricate regulatory environment of the global clinical research industry while supporting sustainable growth and ethical business practices.
Explore Leadership Teams in Business Services
Syneos Health, founded in 1998, is a global biopharmaceutical research and development services company that provides integrated clinical and commercial solutions. The company operates across more than 110 countries, offering expertise in clinical trials, medical affairs, and commercial strategy to help bring therapies to market faster. Syneos Health leverages advanced technologies and data-driven insights to address modern healthcare challenges and improve patient outcomes. The company serves pharmaceutical, biotechnology, and healthcare organizations worldwide with specialized services including clinical research, consulting, and marketing. Headquartered in the United States with significant operations across Europe, Asia Pacific, Africa, and the Americas, Syneos Health maintains a global presence in the life sciences industry.
Company Leadership
SK
PM
MH
Oak Ridge National Laboratory, founded in 1943 and headquartered in Oak Ridge, Tennessee, is an American multiprogram science and technology national laboratory sponsored by the U.S. Department of Energy (DOE) and administered, managed, and operated by UTBattelle as a federally funded research and development center (FFRDC) under a contract with the DOE.
Company Leadership AP
BA
MS
Westat, Inc. provides innovative professional services aimed at enhancing outcomes in health, education, social policy, and transportation. The company specializes in clinical research, biostatistics, epidemiology, and data science, catering to both federal and commercial clients. With a focus on improving lives through research, Westat employs advanced technologies and interdisciplinary expertise to deliver high-quality insights and solutions. Their services are designed to meet the diverse needs of clients, including government agencies and organizations in the healthcare sector.
Company Leadership

DF
CC
L&T Technology Services (LTTS) is a leading global engineering services and digital solutions company that provides comprehensive product engineering and technology consulting services across multiple industries. The company specializes in helping clients with digital transformation, product development, engineering design, embedded systems, software development, and advanced technology solutions including artificial intelligence, Internet of Things, cloud computing, and data analytics. LTTS serves a diverse range of sectors including automotive and transportation, aerospace and defense, industrial products, medical devices, telecommunications, consumer electronics, energy and utilities, and process industries. The company offers end-to-end engineering services spanning the entire product lifecycle from concept and design through prototyping, testing, manufacturing support, and sustenance engineering. LTTS combines deep domain expertise with cutting-edge technology capabilities to help clients accelerate innovation, improve operational efficiency, and bring products to market faster. As a subsidiary of Larsen & Toubro, one of India's largest conglomerates, LTTS leverages strong engineering heritage while maintaining a global presence with delivery centers and offices across North America, Europe, Asia, and other regions. The company partners with leading global corporations and technology innovators, providing both onsite and offshore engineering resources to support complex projects and drive technological advancement across industries undergoing rapid digital and technological transformation.
Company Leadership SI
SB
AK
MS